AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 156 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $21,000 | -96.0% | 14,362 | -72.3% | 0.00% | -100.0% |
| Q4 2015 | $524,000 | -18.6% | 51,875 | +9.6% | 0.01% | -33.3% |
| Q3 2015 | $644,000 | +75.0% | 47,325 | +144.2% | 0.01% | +80.0% |
| Q2 2015 | $368,000 | -77.2% | 19,380 | -68.6% | 0.01% | -80.0% |
| Q1 2015 | $1,615,000 | -29.6% | 61,730 | -43.7% | 0.02% | -28.6% |
| Q4 2014 | $2,295,000 | -32.6% | 109,615 | +7.5% | 0.04% | -32.7% |
| Q3 2014 | $3,403,000 | -4.5% | 101,959 | -8.2% | 0.05% | -5.5% |
| Q2 2014 | $3,565,000 | +55.9% | 111,082 | +316.4% | 0.06% | +25.0% |
| Q3 2013 | $2,287,000 | -44.4% | 26,679 | -58.9% | 0.04% | -56.4% |
| Q2 2013 | $4,111,000 | – | 64,902 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |